CN103443091B - 方法 - Google Patents
方法 Download PDFInfo
- Publication number
- CN103443091B CN103443091B CN201280006090.4A CN201280006090A CN103443091B CN 103443091 B CN103443091 B CN 103443091B CN 201280006090 A CN201280006090 A CN 201280006090A CN 103443091 B CN103443091 B CN 103443091B
- Authority
- CN
- China
- Prior art keywords
- aqueous solution
- hydroxy pyrone
- iron
- ferrum
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
Abstract
Description
Claims (19)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1101370.3 | 2011-01-27 | ||
GBGB1101370.3A GB201101370D0 (en) | 2011-01-27 | 2011-01-27 | Process |
PCT/GB2012/050160 WO2012101442A1 (en) | 2011-01-27 | 2012-01-26 | Process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103443091A CN103443091A (zh) | 2013-12-11 |
CN103443091B true CN103443091B (zh) | 2017-05-10 |
Family
ID=43769665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280006090.4A Active CN103443091B (zh) | 2011-01-27 | 2012-01-26 | 方法 |
Country Status (14)
Country | Link |
---|---|
US (2) | US9096629B2 (zh) |
EP (2) | EP2668175B2 (zh) |
JP (1) | JP6055781B2 (zh) |
KR (1) | KR101925103B1 (zh) |
CN (1) | CN103443091B (zh) |
AU (1) | AU2012210337B2 (zh) |
BR (1) | BR112013018762A2 (zh) |
CA (1) | CA2824931C (zh) |
ES (2) | ES2918004T3 (zh) |
GB (1) | GB201101370D0 (zh) |
RU (1) | RU2621681C2 (zh) |
SG (1) | SG192153A1 (zh) |
WO (1) | WO2012101442A1 (zh) |
ZA (1) | ZA201305221B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015101971A1 (en) * | 2014-01-06 | 2015-07-09 | Iron Therapeutics Holdings Ag | Dosage regimen of ferric trimaltol |
GB201404390D0 (en) * | 2014-03-12 | 2014-04-23 | Iron Therapeutics Holdings Ag | Composition |
US10172882B2 (en) | 2014-06-22 | 2019-01-08 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
GB201418710D0 (en) | 2014-10-21 | 2014-12-03 | Iron Therapeutics Holdings Ag | Dosage regimen |
GB2531742B (en) | 2014-10-28 | 2016-10-05 | Iron Therapeutics Holdings Ag | Polymorphs of ferric maltol |
AU2016205030B2 (en) * | 2015-01-09 | 2021-04-01 | The Board Of Trustees Of The University Of Illinois | Restoring physiology in iron-deficient organisms using small molecules |
EP3435999B1 (en) | 2016-03-31 | 2021-04-28 | Shield TX (UK) Limited | Ferric maltol compositions for use in the treatment or prevention of cancer and tumours |
US11267836B2 (en) | 2016-03-31 | 2022-03-08 | Shield TX (UK) Limited | Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides |
EP3436442B1 (en) | 2016-03-31 | 2020-10-28 | Shield TX (UK) Limited | Methods for producing ferric maltol compositions from ferrous hydroxides |
CN109071481B (zh) * | 2016-03-31 | 2022-09-30 | 英国神盾Tx股份有限公司 | 用于由元素铁产生麦芽酚铁组合物的方法 |
IT202100018578A1 (it) * | 2021-07-14 | 2023-01-14 | Indena Spa | Dispersione amorfa di maltolo ferrico e relativo processo di preparazione |
CN114113066B (zh) * | 2021-12-27 | 2023-09-29 | 西北农林科技大学 | 麦芽酚铁过氧化物模拟酶在检测过氧化氢和总抗氧化能力中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0120670D0 (en) * | 2000-08-25 | 2001-10-17 | Truetzschler Gmbh & Co Kg | Apparatus on an autoleveller draw frame for determination of index values for the regulation starting point |
USRE37534E1 (en) * | 1982-10-22 | 2002-01-29 | Btg International Limited | Pharmaceutical compositions |
CN1408364A (zh) * | 2002-09-20 | 2003-04-09 | 单玉华 | 一类补铁剂干混悬剂的处方组成 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54101445A (en) * | 1978-01-27 | 1979-08-10 | Sanei Kagaku Kogyo Kk | Perfume maltol preparation |
GB2128998B (en) | 1982-10-22 | 1986-07-16 | Nat Res Dev | Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone |
GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
GB8410290D0 (en) | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
GB8410289D0 (en) | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
ES2230564T3 (es) | 1995-06-10 | 2005-05-01 | Vitra Pharmaceuticals Ltd. | Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds. |
JP2000191516A (ja) * | 1998-10-23 | 2000-07-11 | Taisho Pharmaceut Co Ltd | 経口固形組成物 |
US20030190355A1 (en) * | 2002-04-05 | 2003-10-09 | Hermelin Marc S. | Modified release minerals |
GB0211500D0 (en) * | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
WO2005065648A2 (en) * | 2003-12-29 | 2005-07-21 | Alza Corporation, Inc., | Novel drug compositions and dosage forms of topiramate |
EP2015647A2 (en) * | 2004-10-08 | 2009-01-21 | Unilever N.V. | Iron complex for use in the treatment and/or prevention of nutritional disorders |
GB0808835D0 (en) | 2008-05-15 | 2008-06-18 | Vitra Pharmaceuticals Ltd | Therapeutic compositions |
JP2011525916A (ja) * | 2008-06-25 | 2011-09-29 | エフイー3 メディカル, インコーポレイテッド | 治療有効量の鉄の経皮送達用のパッチおよび方法 |
-
2011
- 2011-01-27 GB GBGB1101370.3A patent/GB201101370D0/en not_active Ceased
-
2012
- 2012-01-26 AU AU2012210337A patent/AU2012210337B2/en active Active
- 2012-01-26 CN CN201280006090.4A patent/CN103443091B/zh active Active
- 2012-01-26 ES ES17158230T patent/ES2918004T3/es active Active
- 2012-01-26 SG SG2013056981A patent/SG192153A1/en unknown
- 2012-01-26 CA CA2824931A patent/CA2824931C/en active Active
- 2012-01-26 WO PCT/GB2012/050160 patent/WO2012101442A1/en active Application Filing
- 2012-01-26 KR KR1020137022561A patent/KR101925103B1/ko active IP Right Grant
- 2012-01-26 JP JP2013550951A patent/JP6055781B2/ja active Active
- 2012-01-26 EP EP12708368.1A patent/EP2668175B2/en active Active
- 2012-01-26 ES ES12708368T patent/ES2627089T5/es active Active
- 2012-01-26 RU RU2013139544A patent/RU2621681C2/ru active
- 2012-01-26 US US13/981,551 patent/US9096629B2/en active Active
- 2012-01-26 EP EP17158230.7A patent/EP3192793B1/en active Active
- 2012-01-26 BR BR112013018762A patent/BR112013018762A2/pt not_active Application Discontinuation
-
2013
- 2013-07-11 ZA ZA2013/05221A patent/ZA201305221B/en unknown
-
2015
- 2015-06-25 US US14/750,462 patent/US20150320863A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE37534E1 (en) * | 1982-10-22 | 2002-01-29 | Btg International Limited | Pharmaceutical compositions |
GB0120670D0 (en) * | 2000-08-25 | 2001-10-17 | Truetzschler Gmbh & Co Kg | Apparatus on an autoleveller draw frame for determination of index values for the regulation starting point |
CN1408364A (zh) * | 2002-09-20 | 2003-04-09 | 单玉华 | 一类补铁剂干混悬剂的处方组成 |
Non-Patent Citations (2)
Title |
---|
A potential Iron Pharmaceutical Composition for the Treatment of Iron-deficiency Anaemia.The Crystal and Molecular Structure of mer-Tris-(3-hydroxy-2-methyl-4H-pyran-4-onato)iron(III);Mustafa T.Ahmet,等;《J.Chem.Soc.Dalton Tran.》;19881231(第5期);第1159-1162页 * |
Iron(III) and aluminum(III)complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives;Valeria Marina Nurchi,等;《Journal of Inorganic Biochemistry》;20100501;第104卷(第5期);摘要,第2-3部分 * |
Also Published As
Publication number | Publication date |
---|---|
ES2918004T3 (es) | 2022-07-13 |
KR101925103B1 (ko) | 2018-12-05 |
WO2012101442A1 (en) | 2012-08-02 |
CA2824931C (en) | 2019-08-06 |
US9096629B2 (en) | 2015-08-04 |
ES2627089T3 (es) | 2017-07-26 |
KR20140022377A (ko) | 2014-02-24 |
AU2012210337B2 (en) | 2014-07-17 |
RU2013139544A (ru) | 2015-03-10 |
EP3192793B1 (en) | 2022-03-16 |
EP2668175B1 (en) | 2017-03-08 |
RU2621681C2 (ru) | 2017-06-07 |
GB201101370D0 (en) | 2011-03-09 |
JP6055781B2 (ja) | 2016-12-27 |
JP2014503579A (ja) | 2014-02-13 |
EP2668175A1 (en) | 2013-12-04 |
CA2824931A1 (en) | 2012-08-02 |
EP2668175B2 (en) | 2021-01-06 |
BR112013018762A2 (pt) | 2016-10-25 |
SG192153A1 (en) | 2013-08-30 |
US20150320863A1 (en) | 2015-11-12 |
AU2012210337A1 (en) | 2013-03-21 |
ZA201305221B (en) | 2021-06-30 |
US20140088064A1 (en) | 2014-03-27 |
CN103443091A (zh) | 2013-12-11 |
EP3192793A1 (en) | 2017-07-19 |
ES2627089T5 (es) | 2021-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103443091B (zh) | 方法 | |
CN103641858B (zh) | 一种富马酸替诺福韦二吡呋酯及其制备方法 | |
Köse et al. | Boric acid complexes with thiamine (vitamin B1) and pyridoxine (vitamin B6) | |
ES2283771T3 (es) | Metodos para la formacion de compuestos de hidroc[xipirona de hierro. | |
CN105541573B (zh) | 一种制备2,6,11,15‑四甲基‑2,4,6,8,10,12,14‑十六碳七烯二醛的方法 | |
CN102260293B (zh) | 以氧化海罂粟碱为配体的过渡金属配合物及其合成方法和应用 | |
Grirrane et al. | Thiodiacetate cobalt (II) complexes: Synthesis, structure and properties | |
KR101882517B1 (ko) | 알킬 포스페이트의 제조 방법 | |
CN104903333A (zh) | 一种液态锡(ii)醇盐的制备方法 | |
CN107903263A (zh) | 一种帕布昔利布中间体的合成方法 | |
CN106977552B (zh) | 枸橼酸焦磷酸铁混配络合物的制备方法 | |
CN103145977B (zh) | 一种mPEG2000-DSPE钠盐的制备方法 | |
Das et al. | Associative combination of lone pair–π, π–π and anion–π interactions observed in a ternary system comprising Mg (II)-malonate–2-aminopyridine–hexafluoridophosphate | |
US20230338545A1 (en) | Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation | |
DeBruin et al. | Preferential mode for nucleophilic attack by methoxide ion on O, S-dimethyl phenylphosphonothiolate. Contrasting behavior to reactions on analogous phosphonium salts | |
CN100567309C (zh) | (e)-3,5-二甲氧基二苯乙烯-4'-0-磷酸酯(盐)及其制备方法、药物组合物和用途 | |
CN104478908A (zh) | 以氧化南天竹啡碱为配体的锌、钴金属配合物及其合成方法和应用 | |
US2890233A (en) | Iron-containing organic compounds | |
CN110407868A (zh) | 一种二苯乙烯或二苯乙烷类化合物的磷酰化物制备方法 | |
Hill et al. | CCLXXXVII.—The constitution of the glycerophosphates | |
US978792A (en) | Quinin ester. | |
CN104557503A (zh) | 一种大黄素配合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1192229 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1192229 Country of ref document: HK |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210420 Address after: Gateshead, UK Patentee after: MEDICAL RESEARCH COUNCIL Address before: Waller, Switzerland Patentee before: IRON THERAPEUTICS HOLDINGS AG |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20131211 Assignee: JIANGSU AOSAIKANG PHARMACEUTICAL Co.,Ltd. Assignor: MEDICAL RESEARCH COUNCIL Contract record no.: X2022990000590 Denomination of invention: method Granted publication date: 20170510 License type: Exclusive License Record date: 20220901 |